From 2013 to 2023, the value of sold production of composite diagnostic or laboratory reagents in the Netherlands has seen a significant upward trajectory, particularly from 2019 onwards. Starting with a value of 60.825 million Euros in 2013, we observe fluctuations until 2018 when the trend emerges with impressive growth rates. The year-on-year increase peaked in 2020 with a staggering 106.16% and continued with a strong positive trend, achieving a value of 414.72 million Euros in 2023, marking a 16.4% annual growth from the previous year.
The Compound Annual Growth Rate (CAGR) from 2018 to 2023 stands at 45.46%, underlining the sector's robust expansion during these five years. For the forecasted years from 2024 to 2028, the sector is expected to continue this growth momentum, albeit at a more moderated pace with a projected CAGR of 8.12%, reaching a value of 698.23 million Euros by 2028.
Future trends to watch for:
• Technological advancements in diagnostic and laboratory reagents.
• Rising global and regional demand for rapid and accurate diagnostic solutions.
• Increasing healthcare expenditure and investment in medical research.
• Expansion into emerging markets and the potential impact of regulatory changes.
